Archer Investment Corp
Source: SEC Form 13F · as of Mar 2026Archer Investment Corp holds 17 biotech & pharma companies tracked by BioSniper, totaling $2.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$2.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 7,278 | $1.0M |
| ORKAOruka Therapeutics, Inc. | 6,546 | $321K |
| LQDALiquidia Corp | 6,859 | $259K |
| SNYSanofi | 4,072 | $196K |
| PVLAPALVELLA THERAPEUTICS, INC. | 449 | $56K |
| IONSIONIS PHARMACEUTICALS INC | 600 | $45K |
| IBRXImmunityBio, Inc. | 5,872 | $45K |
| GALTGALECTIN THERAPEUTICS INC | 13,501 | $38K |
| MRNAModerna, Inc. | 520 | $26K |
| APLSApellis Pharmaceuticals, Inc. | 500 | $20K |
| EXELEXELIXIS, INC. | 400 | $17K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 200 | $11K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 70 | $4K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 10 | $3K |
| JAZZJazz Pharmaceuticals plc | 6 | $1K |
| OGNOrganon & Co. | 50 | $300 |
| VXRTVaxart, Inc. | 15 | $9 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.